CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net sales	$ 29,577	$ 19,004	$ 81,225	$ 51,424
Cost of sales	3,886	3,319	11,366	9,394
Gross profit	25,691	15,685	69,859	42,030
Operating expenses:
Selling, general and administrative	16,854	11,237	44,262	31,569
Research and development	7,807	6,173	21,824	18,752
Total operating expenses	24,661	17,410	66,086	50,321
Income (loss) from operations	1,030	(1,725)	3,773	(8,291)
Other income (expense), net
Interest and other income	314	10	935	10
Loss on deconsolidation of DOSE				(25,685)
Loss on extinguishment of debt		(195)		(195)
Interest and other expense, net	(45)	(178)	(223)	(740)
Change in fair value of stock warrant liability		31	43	(1,130)
Total other income (expense), net	269	(332)	755	(27,740)
Income (loss) before taxes	1,299	(2,057)	4,528	(36,031)
Provision for income taxes	140		140
Net income (loss)	1,159	(2,057)	4,388	(36,031)
Net loss attributable to noncontrolling interest				(1,080)
Net income (loss) attributable to Glaukos Corporation	$ 1,159	$ (2,057)	$ 4,388	$ (34,951)
Basic net income (loss) per share attributable to Glaukos Corporation stockholders	$ 0.03	$ (0.06)	$ 0.13	$ (2.78)
Diluted net income (loss) per share attributable to Glaukos Corporation stockholders	$ 0.03	$ (0.07)	$ 0.12	$ (2.78)
Weighted average shares used to compute basic net income (loss) per share attributable to Glaukos Corporation stockholders	33,116	32,006	32,691	12,551
Weighted average shares used to compute diluted net income (loss) per share attributable to Glaukos Corporation stockholders	37,023	32,013	36,259	12,551